category,over_represented_pvalue,under_represented_pvalue,numDEInCat,numInCat,Annotation,ontology
ARA:PWY-1186,2.2130779826952673e-5,0.9999998074103541,3,8,L-homomethionine biosynthesis,BioCyc
ARA:PWY-5441,5.031819226593505e-4,0.9999965631707907,2,5,S-methyl-L-methionine cycle,BioCyc
ARA:LEUSYN-PWY,0.00120115959587415,0.9999475331284566,3,27,L-leucine biosynthesis,BioCyc
ARA:PWYQT-4450,0.0021434766309222455,0.9999624924315745,2,9,"aliphatic glucosinolate biosynthesis, side chain elongation cycle",BioCyc
ARA:BRANCHED-CHAIN-AA-SYN-PWY,0.0025967123160121437,0.999848013301536,3,37,superpathway of branched chain amino acid biosynthesis,BioCyc
ARA:PWY-724,0.0035093497743189273,0.9997701431725312,3,41,"superpathway of L-lysine, L-threonine and L-methionine biosynthesis II",BioCyc
ARA:PWY-5342,0.0060274613437738085,1,1,1,ajugose biosynthesis I (galactinol-dependent),BioCyc
ARA:PWY-702,0.008154859718349736,0.9996861141785213,2,18,L-methionine biosynthesis II,BioCyc
ARA:PWY-6842,0.00836718736619749,0.9988578222759352,4,71,glutathione-mediated detoxification II,BioCyc
ARA:PWY-6902,0.012819171584103955,0.9993867051567281,2,15,chitin degradation II (Vibrio),BioCyc
ARA:PWY-5271,0.016018789177768028,0.9999373527573576,1,2,phaseic acid biosynthesis,BioCyc
ARA:PWY-7640,0.016018789177768028,0.9999373527573576,1,2,neophaseic acid biosynthesis,BioCyc
ARA:PWY-641,0.035541013477115434,0.9995340890818832,1,4,proanthocyanidins biosynthesis from flavanols,BioCyc
ARA:PWY-5670,0.04536653889282092,0.9991301303561313,1,7,epoxysqualene biosynthesis,BioCyc
ARA:PWY-2181,0.047419820899295556,0.9991113827024027,1,5,free phenylpropanoid acid biosynthesis,BioCyc
ARA:ASPARAGINE-DEG1-PWY,0.05941685437174759,0.9985402679007298,1,6,L-asparagine degradation I,BioCyc
ARA:HOMOSERSYN-PWY,0.060079577035673015,0.9983899559286944,1,10,L-homoserine biosynthesis,BioCyc
ARA:PWYQT-4476,0.06763046826547381,0.9980093636666315,1,8,indole glucosinolate activation (herbivore attack),BioCyc
ARA:PWY-5203,0.06875742860973619,0.9979095605615782,1,9,soybean saponin I biosynthesis,BioCyc
ARA:PWY-5125,0.07773798904670369,0.9973590386221483,1,8,anthocyanin biosynthesis,BioCyc
ARA:PWY-5267,0.0781761853063479,0.9972873494428128,1,9,glucosinolate activation,BioCyc
ARA:ASPSYNII-PWY,0.08172811210179805,0.9969948494039287,1,10,cyanide detoxification I,BioCyc
ARA:PWY-4321,0.08569048285691229,0.9966315748919122,1,12,L-glutamate degradation IV,BioCyc
ARA:PWY-5337,0.09182041733617485,0.996122993087908,1,12,stachyose biosynthesis,BioCyc
ARA:PWY-5934,0.10204603501954146,0.9951314750426112,1,14,iron reduction and absorption,BioCyc
ARA:PWY-7177,0.1060507034810963,0.9946467160618077,1,18,UTP and CTP dephosphorylation II,BioCyc
ARA:PWYQT-4471,0.10675011081277384,0.9824698583118376,2,54,glucosinolate biosynthesis from dihomomethionine,BioCyc
ARA:PWY-6792,0.11023718193593975,0.9944690942476598,1,10,scopoletin biosynthesis,BioCyc
ARA:PWY-1001,0.11228968646712549,0.993949580797115,1,20,cellulose biosynthesis,BioCyc
ARA:PWY-7186,0.12047374643924107,0.9931306664215502,1,15,superpathway of scopolin and esculin biosynthesis,BioCyc
ARA:GLYOXYLATE-BYPASS,0.12300375168554833,0.9927741546930143,1,17,glyoxylate cycle,BioCyc
ARA:PWY-6663,0.1254488920633525,0.9924293410081064,1,19,plant sterol biosynthesis II,BioCyc
ARA:PWY-5097,0.13357786981535255,0.9913886360687606,1,19,L-lysine biosynthesis VI,BioCyc
ARA:PWY-4361,0.16533104902488682,0.986602859936973,1,20,S-methyl-5-thio-&alpha;-D-ribose 1-phosphate degradation,BioCyc
ARA:PWY-2821,0.17120231415187684,0.9856790973975489,1,18,glucosinolate biosynthesis from phenylalanine,BioCyc
ARA:PWY-7185,0.17374141854568545,0.9849268092551294,1,29,UTP and CTP dephosphorylation I,BioCyc
ARA:ASPASN-ARA-PWY,0.17659320972492848,0.9844701347880147,1,26,superpathway of aspartate and asparagine biosynthesis,BioCyc
ARA:PWY-7398,0.17915272355449727,0.9842209112910497,1,19,coumarins biosynthesis (engineered),BioCyc
ARA:THRESYN-PWY,0.1832048122167281,0.9831956525587262,1,28,superpathway of L-threonine biosynthesis,BioCyc
ARA:GLUTAMINDEG-PWY,0.18347633693869828,0.9831439387363169,1,28,L-glutamine degradation I,BioCyc
ARA:PWYQT-4472,0.20954850168415376,0.977866772586466,1,25,glucosinolate biosynthesis from trihomomethionine,BioCyc
ARA:PWYQT-4473,0.20954850168415376,0.977866772586466,1,25,glucosinolate biosynthesis from tetrahomomethionine,BioCyc
ARA:PWYQT-4474,0.20954850168415376,0.977866772586466,1,25,glucosinolate biosynthesis from pentahomomethionine,BioCyc
ARA:PWY-5936,0.21056615758347497,0.9776086656078639,1,26,xyloglucan biosynthesis,BioCyc
ARA:PWY-7416,0.21847585553068136,0.9757817776871751,1,27,"phospholipid remodeling (phosphatidylcholine, yeast)",BioCyc
ARA:LEU-DEG2-PWY,0.2228929640801236,0.974606370838477,1,32,L-leucine degradation I,BioCyc
ARA:PWY-7176,0.22524008893400155,0.9741226311597077,1,29,UTP and CTP de novo biosynthesis,BioCyc
ARA:PWY-7450,0.2261793277561659,0.974032848075223,1,25,anthocyanidin modification (Arabidopsis),BioCyc
ARA:CITRULBIO-PWY,0.2264387032072996,0.9736864830739304,1,35,L-citrulline biosynthesis,BioCyc
ARA:PWY-5868,0.22849840513309355,0.9733630318806414,1,28,simple coumarins biosynthesis,BioCyc
ARA:PWY-581,0.23646721354008643,0.9712824093165056,1,31,indole-3-acetate biosynthesis II,BioCyc
ARA:PWYQT-4475,0.24736921584657978,0.968426876199886,1,31,glucosinolate biosynthesis from hexahomomethionine,BioCyc
ARA:PWY-3001,0.25521467828042793,0.9660310213337822,1,41,superpathway of L-isoleucine biosynthesis I,BioCyc
ARA:PWY0-162,0.2595481168515451,0.9649384035133682,1,35,superpathway of pyrimidine ribonucleotides de novo biosynthesis,BioCyc
ARA:PWY-1187,0.26824367378631725,0.9625366109034376,1,31,glucosinolate biosynthesis from homomethionine,BioCyc
ARA:PWY-5687,0.27434380211420184,0.9604924347501677,1,38,pyrimidine ribonucleotides interconversion,BioCyc
ARA:PWY-7208,0.27929704970614155,0.9589146174918681,1,40,superpathway of pyrimidine nucleobases salvage,BioCyc
ARA:PWY-1081,0.28244597535655114,0.9579755913828805,1,38,homogalacturonan degradation,BioCyc
ARA:PWY-2541,0.3052079158374365,0.9502696851163683,1,44,plant sterol biosynthesis,BioCyc
ARA:PWY-7196,0.3217711563414107,0.9442393491467871,1,47,superpathway of pyrimidine ribonucleosides salvage,BioCyc
ARA:PWY-7270,0.322103209115889,0.9442711946164992,1,41,L-methionine salvage cycle II (plants),BioCyc
ARA:PWY-1121,0.370968620537989,0.9239904671980518,1,54,suberin monomers biosynthesis,BioCyc
ARA:PWY-7211,0.4049645888389614,0.9077563851709312,1,61,superpathway of pyrimidine deoxyribonucleotides de novo biosynthesis,BioCyc
ARA:PWY-6443,0.41813497385003384,0.9011941867934332,1,54,"benzoate biosynthesis I (CoA-dependent, &beta;-oxidative)",BioCyc
ARA:PWY-6803,0.4311673815191229,0.8939733113504708,1,65,phosphatidylcholine acyl editing,BioCyc
ARA:LIPASYN-PWY,0.45209189756677504,0.882038771682735,1,72,phospholipases,BioCyc
ARA:PWY-181,0.9999999999999988,0.7357600911877984,0,36,photorespiration,BioCyc
ARA:PWY-5123,0.9999999999999992,0.8080541781848876,0,21,"trans, trans-farnesyl diphosphate biosynthesis",BioCyc
ARA:PWY-3781,0.9999999999999996,0.3252133166511841,0,104,aerobic respiration I (cytochrome c),BioCyc
ARA:PWY-5661,0.9999999999999996,0.9063361774574814,0,16,GDP-glucose biosynthesis,BioCyc
ARA:PWY66-399,0.9999999999999998,0.5900174219469931,0,62,gluconeogenesis III,BioCyc
ARA:ALACAT2-PWY,1,0.911163471251421,0,12,L-alanine degradation II (to D-lactate),BioCyc
ARA:ALANINE-DEG3-PWY,1,0.9435120739951985,0,8,L-alanine degradation III,BioCyc
ARA:ALANINE-SYN2-PWY,1,0.9435120739951985,0,8,L-alanine biosynthesis II,BioCyc
ARA:ARG-PRO-PWY,1,0.9629742683779372,0,4,L-arginine degradation VI (arginase 2 pathway),BioCyc
ARA:ARGASEDEG-PWY,1,0.9779326555705526,0,3,L-arginine degradation I (arginase pathway),BioCyc
ARA:ARGDEG-V-PWY,1,0.9790774566447908,0,3,L-arginine degradation X (arginine monooxygenase pathway),BioCyc
ARA:ARGININE-SYN4-PWY,1,0.9542569052633784,0,6,L-ornithine biosynthesis II,BioCyc
ARA:ARGSPECAT-PWY,1,0.9003064732703953,0,11,spermine biosynthesis,BioCyc
ARA:ARGSYN-PWY,1,0.8742464182550937,0,16,L-arginine biosynthesis I (via L-ornithine),BioCyc
ARA:ARGSYNBSUB-PWY,1,0.8819732020461266,0,15,L-arginine biosynthesis II (acetyl cycle),BioCyc
ARA:ASPARAGINE-BIOSYNTHESIS,1,0.9630637211173195,0,6,L-asparagine biosynthesis I,BioCyc
ARA:ASPARAGINESYN-PWY,1,0.9630637211173195,0,6,L-asparagine biosynthesis II,BioCyc
ARA:ASPARTATE-DEG1-PWY,1,0.9093306503399375,0,14,L-aspartate degradation I,BioCyc
ARA:ASPARTATESYN-PWY,1,0.9093306503399375,0,14,L-aspartate biosynthesis,BioCyc
ARA:BSUBPOLYAMSYN-PWY,1,0.8924722639620866,0,12,spermidine biosynthesis I,BioCyc
ARA:CAMALEXIN-SYN,1,0.754615845845936,0,29,camalexin biosynthesis,BioCyc
ARA:CHLOROPHYLL-SYN,1,0.8174016551603812,0,22,"3,8-divinyl-chlorophyllide a biosynthesis I (aerobic, light-dependent)",BioCyc
ARA:CITRULLINE-DEG-PWY,1,0.9902122070476369,0,1,L-citrulline degradation,BioCyc
ARA:COA-PWY,1,0.9082387861611478,0,9,coenzyme A biosynthesis I,BioCyc
ARA:COMPLETE-ARO-ARA-PWY,1,0.7214572247040353,0,38,"superpathway of phenylalanine, tyrosine and tryptophan biosynthesis",BioCyc
ARA:CYANCAT-PWY,1,0.9677070228192242,0,3,cyanate degradation,BioCyc
ARA:CYSTSYN-PWY,1,0.7994061923104048,0,25,L-cysteine biosynthesis I,BioCyc
ARA:DETOX1-PWY,1,0.839210472181576,0,21,superoxide radicals degradation,BioCyc
ARA:DETOX1-PWY-1,1,0.7725281675325919,0,28,reactive oxygen species degradation,BioCyc
ARA:ETHYL-PWY,1,0.7558341242048194,0,31,ethylene biosynthesis I (plants),BioCyc
ARA:ETOH-ACETYLCOA-ANA-PWY,1,0.9080164211049727,0,12,ethanol degradation I,BioCyc
ARA:FASYN-ELONG-PWY,1,0.8589034324112379,0,15,fatty acid elongation -- saturated,BioCyc
ARA:GLNSYN-PWY,1,0.9238534655098086,0,10,L-glutamine biosynthesis I,BioCyc
ARA:GLUCONEO-PWY,1,0.6147395523734381,0,60,gluconeogenesis I,BioCyc
ARA:GLUCOSE1PMETAB-PWY,1,0.8758734125261292,0,21,glucose and glucose-1-phosphate degradation,BioCyc
ARA:GLUGLNSYN-PWY,1,0.9879964756856529,0,3,L-glutamate biosynthesis IV,BioCyc
ARA:GLUT-REDOX-PWY,1,0.9770245369023843,0,4,glutathione-glutaredoxin redox reactions,BioCyc
ARA:GLUTAMATE-DEG1-PWY,1,0.9657759413732632,0,4,L-glutamate degradation I,BioCyc
ARA:GLUTAMATE-SYN2-PWY,1,0.9657759413732632,0,4,L-glutamate biosynthesis II,BioCyc
ARA:GLUTATHIONESYN-PWY,1,0.9815566199187689,0,3,glutathione biosynthesis,BioCyc
ARA:GLUTORN-PWY,1,0.9085776093467377,0,11,L-ornithine biosynthesis I,BioCyc
ARA:GLUTSYNIII-PWY,1,0.9554127438413529,0,6,L-glutamate biosynthesis III,BioCyc
ARA:GLYCLEAV-PWY,1,0.8656115368796792,0,17,glycine cleavage,BioCyc
ARA:GLYCOLYSIS,1,0.632862025463202,0,57,glycolysis I (from glucose 6-phosphate),BioCyc
ARA:GLYOXDEG-PWY,1,0.987317001689007,0,2,glycolate and glyoxylate degradation II,BioCyc
ARA:GLYSYN-ALA-PWY,1,0.9145956017946766,0,12,glycine biosynthesis III,BioCyc
ARA:GLYSYN-PWY,1,0.9206664775478733,0,11,glycine biosynthesis I,BioCyc
ARA:GLYSYN2-PWY,1,0.8616345492116068,0,20,glycine biosynthesis,BioCyc
ARA:HEME-BIOSYNTHESIS-II,1,0.8956765745803312,0,14,heme biosynthesis I (aerobic),BioCyc
ARA:HEXPPSYN-PWY,1,0.9828807135257397,0,2,hexaprenyl diphosphate biosynthesis,BioCyc
ARA:HISTSYN-PWY,1,0.8764399585998467,0,16,L-histidine biosynthesis,BioCyc
ARA:HOMOCYSDEGR-PWY,1,0.991440631660199,0,1,L-cysteine biosynthesis III (from L-homocysteine),BioCyc
ARA:HOMOSER-THRESYN-PWY,1,0.9560417615005213,0,4,L-threonine biosynthesis,BioCyc
ARA:ILE-VAL-PWY,1,0.8796181809738052,0,19,superpathway of isoleucine and valine biosynthesis,BioCyc
ARA:ILEUDEG-PWY,1,0.8505893855727408,0,20,L-isoleucine degradation I,BioCyc
ARA:ILEUSYN-PWY,1,0.9186120447938473,0,12,L-isoleucine biosynthesis I (from threonine),BioCyc
ARA:KDOSYN-PWY,1,0.9850652490768413,0,2,Kdo transfer to lipid IVA I,BioCyc
ARA:LCYSDEG-PWY,1,0.9894282695232635,0,1,L-cysteine degradation II,BioCyc
ARA:LIPAS-PWY,1,0.4573957261288662,0,93,triacylglycerol degradation,BioCyc
ARA:LYSINE-DEG2-PWY,1,0.9211247990144407,0,12,lysine degradation II,BioCyc
ARA:MALATE-ASPARTATE-SHUTTLE-PWY,1,0.8534798510733355,0,21,L-aspartate degradation II,BioCyc
ARA:MANNCAT-PWY,1,0.9654537799697749,0,4,D-mannose degradation,BioCyc
ARA:MANNOSYL-CHITO-DOLICHOL-BIOSYNTHESIS,1,0.8054319431255915,0,25,"protein N-glycosylation (eukaryotic, high mannose)",BioCyc
ARA:METHIONINE-DEG1-PWY,1,0.9159196641245494,0,9,L-methionine degradation I (to L-homocysteine),BioCyc
ARA:NAGLIPASYN-PWY,1,0.8996425713406769,0,11,lipid IVA biosynthesis,BioCyc
ARA:NONMEVIPP-PWY,1,0.8887579910643238,0,15,methylerythritol phosphate pathway I,BioCyc
ARA:NONOXIPENT-PWY,1,0.8649380873781506,0,16,pentose phosphate pathway (non-oxidative branch),BioCyc
ARA:OXIDATIVEPENT-PWY,1,0.8375208935779085,0,20,pentose phosphate pathway (oxidative branch) I,BioCyc
ARA:P401-PWY,1,0.9249967549721494,0,9,cyanide degradation,BioCyc
ARA:PANTO-PWY,1,0.9442188427952894,0,7,phosphopantothenate biosynthesis I,BioCyc
ARA:PENTOSE-P-PWY,1,0.7238187340613947,0,36,pentose phosphate pathway,BioCyc
ARA:PHOSLIPSYN2-PWY,1,0.9542709862591746,0,6,superpathway of phospholipid biosynthesis II (plants),BioCyc
ARA:PHOTOALL-PWY,1,0.4002070658866596,0,85,oxygenic photosynthesis,BioCyc
ARA:PLPSAL-PWY,1,0.9639265249733749,0,5,pyridoxal 5'-phosphate salvage I,BioCyc
ARA:POLYAMINSYN3-PWY,1,0.9767292320449262,0,3,superpathway of polyamine biosynthesis II,BioCyc
ARA:PROSYN-PWY,1,0.9734010758635927,0,3,L-proline biosynthesis I,BioCyc
ARA:PROUT-PWY,1,0.9725285521494454,0,4,L-proline degradation,BioCyc
ARA:PWY-101,1,0.5845149958303434,0,46,photosynthesis light reactions,BioCyc
ARA:PWY-102,1,0.9234384324091315,0,9,gibberellin inactivation I (2&beta;-hydroxylation),BioCyc
ARA:PWY-1042,1,0.647623475245405,0,55,glycolysis IV (plant cytosol),BioCyc
ARA:PWY-1061,1,0.7810464890436669,0,29,homogalacturonan biosynthesis,BioCyc
ARA:PWY-112,1,0.9637615194668643,0,5,lupeol biosynthesis,BioCyc
ARA:PWY-116,1,0.9642714280611606,0,4,coniferin metabolism,BioCyc
ARA:PWY-1269,1,0.933806812494987,0,9,CMP-3-deoxy-D-manno-octulosonate biosynthesis,BioCyc
ARA:PWY-1422,1,0.9232730333216415,0,9,vitamin E biosynthesis (tocopherols),BioCyc
ARA:PWY-1581,1,0.9422348368196976,0,6,plastoquinol-9 biosynthesis I,BioCyc
ARA:PWY-1722,1,0.9304821445022482,0,8,"formate assimilation into 5,10-methylenetetrahydrofolate",BioCyc
ARA:PWY-1782,1,0.8800963491423983,0,15,superpathway of indole-3-acetate conjugate biosynthesis,BioCyc
ARA:PWY-1801,1,0.9821325593399785,0,2,formaldehyde oxidation II (glutathione-dependent),BioCyc
ARA:PWY-1822,1,0.934561023642155,0,7,indole-3-acetate activation I,BioCyc
ARA:PWY-1881,1,0.9926215117383425,0,1,formate oxidation to CO2,BioCyc
ARA:PWY-2,1,0.9803647791145991,0,3,putrescine degradation IV,BioCyc
ARA:PWY-2021,1,0.9239931936273322,0,10,indole-3-acetate degradation IV,BioCyc
ARA:PWY-2161,1,0.89180230935595,0,16,folate polyglutamylation,BioCyc
ARA:PWY-2161B,1,0.9516112690958114,0,6,glutamate removal from folates,BioCyc
ARA:PWY-2161B-PMN,1,0.9280951875267821,0,10,folate polyglutamylation II,BioCyc
ARA:PWY-2261,1,0.7732881938253261,0,26,ascorbate glutathione cycle,BioCyc
ARA:PWY-2301,1,0.9528773021976648,0,6,myo-inositol biosynthesis,BioCyc
ARA:PWY-2501,1,0.907743657246632,0,15,fatty acid &alpha;-oxidation I,BioCyc
ARA:PWY-2582,1,0.9448058167011886,0,8,brassinosteroid biosynthesis II,BioCyc
ARA:PWY-2602,1,0.9869861810104771,0,1,brassinosteroid biosynthesis III,BioCyc
ARA:PWY-2681,1,0.8577903129846207,0,17,trans-zeatin biosynthesis,BioCyc
ARA:PWY-2724,1,0.9250784634241132,0,12,alkane oxidation,BioCyc
ARA:PWY-2781,1,0.9865425841364034,0,2,cis-zeatin biosynthesis,BioCyc
ARA:PWY-282,1,0.9269536029585493,0,8,cuticular wax biosynthesis,BioCyc
ARA:PWY-2841,1,0.9527621393656561,0,7,cytokinins degradation,BioCyc
ARA:PWY-2881,1,0.9300602781780026,0,7,cytokinins 7-N-glucoside biosynthesis,BioCyc
ARA:PWY-2901,1,0.9300602781780026,0,7,cytokinins 9-N-glucoside biosynthesis,BioCyc
ARA:PWY-2902,1,0.9283265981039797,0,8,cytokinin-O-glucosides biosynthesis,BioCyc
ARA:PWY-3041,1,0.9698841681330652,0,4,monoterpene biosynthesis,BioCyc
ARA:PWY-3101,1,0.8900056448232835,0,11,flavonol biosynthesis,BioCyc
ARA:PWY-3181,1,0.9734682918534217,0,5,L-tryptophan degradation VI (via tryptamine),BioCyc
ARA:PWY-321,1,0.7432563752850796,0,35,cutin biosynthesis,BioCyc
ARA:PWY-3221,1,0.9891798828298531,0,1,dTDP-L-rhamnose biosynthesis II,BioCyc
ARA:PWY-3261,1,0.9681914691340974,0,4,UDP-L-rhamnose biosynthesis,BioCyc
ARA:PWY-3301,1,0.7337476476061869,0,39,sinapate ester biosynthesis,BioCyc
ARA:PWY-3341,1,0.967193161087953,0,4,L-proline biosynthesis III,BioCyc
ARA:PWY-3385,1,0.9003426873769049,0,14,choline biosynthesis I,BioCyc
ARA:PWY-3461,1,0.923439971388645,0,9,L-tyrosine biosynthesis II,BioCyc
ARA:PWY-3462,1,0.8903182368147948,0,13,L-phenylalanine biosynthesis II,BioCyc
ARA:PWY-3481,1,0.8643170788360908,0,16,superpathway of L-phenylalanine and L-tyrosine biosynthesis,BioCyc
ARA:PWY-3561,1,0.8500317514381256,0,26,choline biosynthesis III,BioCyc
ARA:PWY-361,1,0.6086843097192017,0,54,phenylpropanoid biosynthesis,BioCyc
ARA:PWY-3742,1,0.7739529181571684,0,30,tetrahydrofolate biosynthesis II,BioCyc
ARA:PWY-3801,1,0.7507262819048877,0,41,sucrose degradation II (sucrose synthase),BioCyc
ARA:PWY-381,1,0.9049601517098556,0,13,nitrate reduction II (assimilatory),BioCyc
ARA:PWY-3821,1,0.9393499805384299,0,8,D-galactose degradation III,BioCyc
ARA:PWY-3841,1,0.736490190681157,0,38,folate transformations II,BioCyc
ARA:PWY-3881,1,0.9397536354323289,0,7,mannitol biosynthesis,BioCyc
ARA:PWY-3941,1,0.95613781462440806,0,5,&beta;-alanine biosynthesis II,BioCyc
ARA:PWY-3982,1,0.9760844539550719,0,3,uracil degradation I (reductive),BioCyc
ARA:PWY-4,1,0.9819584354459207,0,3,UDP-D-galacturonate biosynthesis II (from D-galacturonate),BioCyc
ARA:PWY-40,1,0.9790774566447908,0,3,putrescine biosynthesis I,BioCyc
ARA:PWY-401,1,0.940301237749285,0,9,galactolipid biosynthesis I,BioCyc
ARA:PWY-4041,1,0.9137669669200679,0,11,&gamma;-glutamyl cycle,BioCyc
ARA:PWY-4081,1,0.86353017026684,0,15,glutathione-peroxide redox reactions,BioCyc
ARA:PWY-4101,1,0.8565313088456974,0,17,D-sorbitol degradation I,BioCyc
ARA:PWY-4203,1,0.9698502661886437,0,3,volatile benzenoid biosynthesis I (ester formation),BioCyc
ARA:PWY-4221ARA,1,0.8574278586392878,0,16,superpathway of pantothenate and coenzymeA biosynthesis,BioCyc
ARA:PWY-4261,1,0.9852150180116661,0,2,glycerol degradation I,BioCyc
ARA:PWY-43,1,0.9544253373882264,0,6,putrescine biosynthesis II,BioCyc
ARA:PWY-4302,1,0.4007743437396872,0,84,aerobic respiration III (alternative oxidase pathway),BioCyc
ARA:PWY-4341,1,0.9920039165711856,0,2,L-glutamate biosynthesis V,BioCyc
ARA:PWY-4381,1,0.9011032291829226,0,14,fatty acid biosynthesis initiation I,BioCyc
ARA:PWY-4541,1,0.9149286462029491,0,9,"lipid-dependent phytate biosynthesis I (via Ins(1,4,5)P3)",BioCyc
ARA:PWY-4562,1,0.8762522639095195,0,15,"lipid-dependent phytate biosynthesis II (via Ins(1,3,4)P3)",BioCyc
ARA:PWY-4661,1,0.8968877164876512,0,14,1D-myo-inositol hexakisphosphate biosynthesis III (Spirodela polyrrhiza),BioCyc
ARA:PWY-4702,1,0.9675626824927008,0,4,phytate degradation I,BioCyc
ARA:PWY-4765,1,0.8762522639095195,0,15,superpathway of lipid-dependent phytate biosynthesis,BioCyc
ARA:PWY-4821,1,0.8680198540402249,0,18,UDP-D-xylose biosynthesis,BioCyc
ARA:PWY-4841,1,0.9408685400403962,0,7,UDP-&alpha;-D-glucuronate biosynthesis (from myo-inositol),BioCyc
ARA:PWY-4861,1,0.9399952095473925,0,6,UDP-D-galacturonate biosynthesis I (from UDP-D-glucuronate),BioCyc
ARA:PWY-4983,1,0.9621676588564105,0,5,L-citrulline-nitric oxide cycle,BioCyc
ARA:PWY-4984,1,0.9527768616171117,0,6,urea cycle,BioCyc
ARA:PWY-5027,1,0.9562604680589221,0,4,phylloquinol biosynthesis,BioCyc
ARA:PWY-5032,1,0.9940513258601132,0,1,ent-kaurene biosynthesis I,BioCyc
ARA:PWY-5034,1,0.9712492798301516,0,4,GA12 biosynthesis,BioCyc
ARA:PWY-5035,1,0.8692129563810783,0,14,gibberellin biosynthesis III (early C-13 hydroxylation),BioCyc
ARA:PWY-5036,1,0.9779876263777674,0,2,gibberellin biosynthesis II (early C-3 hydroxylation),BioCyc
ARA:PWY-5041,1,0.8840871907003147,0,15,S-adenosyl-L-methionine cycle II,BioCyc
ARA:PWY-5043,1,0.8773508172614545,0,15,purine nucleosides salvage II (plant),BioCyc
ARA:PWY-5046,1,0.8721681857278707,0,17,2-oxoisovalerate decarboxylation to isobutanoyl-CoA,BioCyc
ARA:PWY-5049,1,0.988373964759952,0,1,rosmarinic acid biosynthesis II,BioCyc
ARA:PWY-5060,1,0.9620197191819273,0,4,luteolin biosynthesis,BioCyc
ARA:PWY-5063,1,0.9907307527802566,0,1,phytyl diphosphate biosynthesis,BioCyc
ARA:PWY-5064,1,0.9842600762750696,0,2,chlorophyll a biosynthesis II,BioCyc
ARA:PWY-5068,1,0.9584551339943551,0,6,chlorophyll cycle,BioCyc
ARA:PWY-5070,1,0.906132275411095,0,9,"gibberellin biosynthesis I (non C-3, non C-13 hydroxylation)",BioCyc
ARA:PWY-5079,1,0.9358635796550664,0,8,L-phenylalanine degradation III,BioCyc
ARA:PWY-5080,1,0.6909224123773328,0,41,very long chain fatty acid biosynthesis I,BioCyc
ARA:PWY-5083,1,0.47696670164149085,0,70,NAD/NADH phosphorylation and dephosphorylation,BioCyc
ARA:PWY-5084,1,0.8912066322970719,0,15,2-oxoglutarate decarboxylation to succinyl-CoA,BioCyc
ARA:PWY-5086,1,0.9934706805464468,0,1,chlorophyll a biosynthesis I,BioCyc
ARA:PWY-5098,1,0.9350354464182191,0,7,chlorophyll a degradation I,BioCyc
ARA:PWY-5107,1,0.980058212566506,0,2,phytol salvage pathway,BioCyc
ARA:PWY-5111,1,0.9449724949679797,0,8,CMP-KDO biosynthesis II (from D-arabinose 5-phosphate),BioCyc
ARA:PWY-5113,1,0.9856362283675775,0,2,UDP-D-apiose biosynthesis (from UDP-D-glucuronate),BioCyc
ARA:PWY-5114,1,0.7275808439775389,0,39,UDP-sugars interconversion,BioCyc
ARA:PWY-5115,1,0.9929783543196398,0,1,GDP-L-galactose biosynthesis,BioCyc
ARA:PWY-5120,1,0.8472128459125836,0,14,geranylgeranyl diphosphate biosynthesis,BioCyc
ARA:PWY-5121,1,0.7237260339872243,0,34,superpathway of geranylgeranyl diphosphate biosynthesis II (via MEP),BioCyc
ARA:PWY-5122,1,0.8385705674456604,0,16,geranyl diphosphate biosynthesis,BioCyc
ARA:PWY-5129,1,0.7701459728695149,0,32,sphingolipid biosynthesis (plants),BioCyc
ARA:PWY-5136,1,0.8978842961608366,0,14,fatty acid &beta;-oxidation II (peroxisome),BioCyc
ARA:PWY-5138,1,0.9070109871634933,0,10,"unsaturated, even numbered fatty acid &beta;-oxidation",BioCyc
ARA:PWY-5142,1,0.9480330784718275,0,6,acyl-ACP thioesterase pathway,BioCyc
ARA:PWY-5143,1,0.8868701125294515,0,17,long-chain fatty acid activation,BioCyc
ARA:PWY-5147,1,0.7941620048465834,0,30,oleate biosynthesis I (plants),BioCyc
ARA:PWY-5148,1,0.9190182401489057,0,8,acyl-CoA hydrolysis,BioCyc
ARA:PWY-5152,1,0.904237292829079,0,10,leucodelphinidin biosynthesis,BioCyc
ARA:PWY-5168,1,0.9665638959585003,0,4,ferulate and sinapate biosynthesis,BioCyc
ARA:PWY-5172,1,0.9464217577965479,0,8,acetyl-CoA biosynthesis III (from citrate),BioCyc
ARA:PWY-5175,1,0.9930810422368849,0,1,lactucaxanthin biosynthesis,BioCyc
ARA:PWY-5176,1,0.9938119627612749,0,1,coumarin biosynthesis (via 2-coumarate),BioCyc
ARA:PWY-5188,1,0.8996482269510371,0,13,tetrapyrrole biosynthesis I (from glutamate),BioCyc
ARA:PWY-5194,1,0.9559734036721447,0,5,siroheme biosynthesis,BioCyc
ARA:PWY-5269,1,0.9403803339409615,0,6,cardiolipin biosynthesis II,BioCyc
ARA:PWY-5272,1,0.903763589483966,0,9,abscisic acid glucose ester metabolism,BioCyc
ARA:PWY-5285,1,0.980233227814608,0,2,sulfide oxidation III (persulfide dioxygenase),BioCyc
ARA:PWY-5287,1,0.9899712173276679,0,1,sanguinarine and macarpine biosynthesis,BioCyc
ARA:PWY-5313,1,0.9562963701975714,0,4,superpathway of anthocyanin biosynthesis (from cyanidin and cyanidin 3-O-glucoside),BioCyc
ARA:PWY-5320,1,0.8465390769890534,0,16,kaempferol glycoside biosynthesis (Arabidopsis),BioCyc
ARA:PWY-5321,1,0.6163732875089971,0,44,quercetin glycoside biosynthesis (Arabidopsis),BioCyc
ARA:PWY-5326,1,0.9821506369545983,0,2,sulfite oxidation IV,BioCyc
ARA:PWY-5340,1,0.9043354307320408,0,10,sulfate activation for sulfonation,BioCyc
ARA:PWY-5343,1,0.9933392237988773,0,1,ajugose biosynthesis II (galactinol-independent),BioCyc
ARA:PWY-5350,1,0.9012917844302288,0,8,thiosulfate disproportionation IV (rhodanese),BioCyc
ARA:PWY-5366,1,0.9480330784718275,0,6,palmitoleate biosynthesis II (plants and bacteria),BioCyc
ARA:PWY-5377,1,0.969360197891155,0,4,&alpha;-amyrin biosynthesis,BioCyc
ARA:PWY-5381,1,0.6770961499900073,0,40,pyridine nucleotide cycling (plants),BioCyc
ARA:PWY-5386,1,0.8402281231708653,0,22,methylglyoxal degradation I,BioCyc
ARA:PWY-5389,1,0.9652996967537661,0,3,3-methylthiopropanoate biosynthesis,BioCyc
ARA:PWY-5391,1,0.9107013845518396,0,9,syringetin biosynthesis,BioCyc
ARA:PWY-5410,1,0.9270323152138156,0,8,traumatin and (Z)-3-hexen-1-yl acetate biosynthesis,BioCyc
ARA:PWY-5453,1,0.8632983172321789,0,13,methylglyoxal degradation III,BioCyc
ARA:PWY-5466,1,0.9732724206473082,0,3,matairesinol biosynthesis,BioCyc
ARA:PWY-5469,1,0.977419131136214,0,2,sesamin biosynthesis,BioCyc
ARA:PWY-5481,1,0.9881880648559114,0,1,pyruvate fermentation to lactate,BioCyc
ARA:PWY-5484,1,0.5922409499423822,0,63,glycolysis II (from fructose 6-phosphate),BioCyc
ARA:PWY-5486,1,0.8774590397233535,0,16,pyruvate fermentation to ethanol II,BioCyc
ARA:PWY-5530,1,0.9423253801215258,0,5,sorbitol biosynthesis II,BioCyc
ARA:PWY-561,1,0.7429591600974321,0,32,superpathway of glyoxylate cycle and fatty acid degradation,BioCyc
ARA:PWY-5640,1,0.988128250293828,0,1,nitrobenzene degradation II,BioCyc
ARA:PWY-5659,1,0.8631292601528829,0,20,GDP-mannose biosynthesis,BioCyc
ARA:PWY-5667,1,0.8232734172686504,0,25,CDP-diacylglycerol biosynthesis I,BioCyc
ARA:PWY-5669,1,0.9691504141840626,0,5,phosphatidylethanolamine biosynthesis I,BioCyc
ARA:PWY-5686,1,0.9560622358209385,0,6,UMP biosynthesis I,BioCyc
ARA:PWY-5690,1,0.6875108297194713,0,41,TCA cycle II (plants and fungi),BioCyc
ARA:PWY-5691,1,0.9690241309496771,0,3,urate degradation to allantoin I,BioCyc
ARA:PWY-5692,1,0.9866155316069144,0,2,allantoin degradation to glyoxylate II,BioCyc
ARA:PWY-5697,1,0.986908178367444,0,2,allantoin degradation to ureidoglycolate I (urea producing),BioCyc
ARA:PWY-5698,1,0.9740967144078055,0,4,allantoin degradation to ureidoglycolate II (ammonia producing),BioCyc
ARA:PWY-5704,1,0.9942476058135399,0,1,urea degradation II,BioCyc
ARA:PWY-5723,1,0.7042837776719754,0,41,Rubisco shunt,BioCyc
ARA:PWY-5765,1,0.966605176554267,0,4,"1,3,5-trimethoxybenzene biosynthesis",BioCyc
ARA:PWY-5783,1,0.9828807135257397,0,2,octaprenyl diphosphate biosynthesis,BioCyc
ARA:PWY-5788,1,0.9239931936273322,0,10,indole-3-acetate degradation V,BioCyc
ARA:PWY-5791,1,0.9261261495383214,0,9,"1,4-dihydroxy-2-naphthoate biosynthesis II (plants)",BioCyc
ARA:PWY-5800,1,0.8916246073560291,0,14,xylan biosynthesis,BioCyc
ARA:PWY-5805,1,0.9828807135257397,0,2,nonaprenyl diphosphate biosynthesis I,BioCyc
ARA:PWY-5807,1,0.9480003594664805,0,5,heptaprenyl diphosphate biosynthesis,BioCyc
ARA:PWY-5837,1,0.9261261495383214,0,9,"1,4-dihydroxy-2-naphthoate biosynthesis",BioCyc
ARA:PWY-5859,1,0.883254871092416,0,11,eugenol and isoeugenol biosynthesis,BioCyc
ARA:PWY-5871,1,0.9452383979220553,0,8,ubiquinol-9 biosynthesis (eukaryotic),BioCyc
ARA:PWY-5876,1,0.9834600276907198,0,2,magnoflorine biosynthesis,BioCyc
ARA:PWY-5884,1,0.8121013157638263,0,22,wax esters biosynthesis I,BioCyc
ARA:PWY-5886,1,0.9688003869903863,0,4,4-hydroxyphenylpyruvate biosynthesis,BioCyc
ARA:PWY-5905,1,0.9686873802412271,0,3,hypusine biosynthesis,BioCyc
ARA:PWY-5921,1,0.9261325544644561,0,9,glutaminyl-tRNAgln biosynthesis via transamidation,BioCyc
ARA:PWY-5943,1,0.9893995021451211,0,1,&beta;-carotene biosynthesis,BioCyc
ARA:PWY-5944,1,0.9903095281475576,0,1,zeaxanthin biosynthesis,BioCyc
ARA:PWY-5945,1,0.9681405805664587,0,4,"zeaxanthin, antheraxanthin and violaxanthin interconversion",BioCyc
ARA:PWY-5946,1,0.9930810422368849,0,1,&delta;-carotene biosynthesis,BioCyc
ARA:PWY-5947,1,0.9721860267893282,0,4,lutein biosynthesis,BioCyc
ARA:PWY-5957,1,0.9627369597063606,0,3,L-nicotianamine biosynthesis,BioCyc
ARA:PWY-5963,1,0.9187080296710716,0,11,thio-molybdenum cofactor biosynthesis,BioCyc
ARA:PWY-5971,1,0.6905378902643171,0,43,palmitate biosynthesis II (bacteria and plants),BioCyc
ARA:PWY-5973,1,0.779356733964172,0,26,cis-vaccenate biosynthesis,BioCyc
ARA:PWY-5980,1,0.7536942617107779,0,33,xylogalacturonan biosynthesis,BioCyc
ARA:PWY-5986,1,0.9794055191711886,0,2,ammonium transport,BioCyc
ARA:PWY-5989,1,0.7002632028207284,0,41,stearate biosynthesis II (bacteria and plants),BioCyc
ARA:PWY-5992,1,0.6775090897840068,0,42,thalianol and derivatives biosynthesis,BioCyc
ARA:PWY-5995,1,0.9759234398506507,0,3,linoleate biosynthesis I (plants),BioCyc
ARA:PWY-5997,1,0.9784446163226791,0,3,&alpha;-linolenate biosynthesis I (plants and red algae),BioCyc
ARA:PWY-5998,1,0.9866291139392197,0,1,&gamma;-linolenate biosynthesis I (plants),BioCyc
ARA:PWY-6,1,0.9880848382445332,0,2,GDP-L-fucose biosynthesis II (from L-fucose),BioCyc
ARA:PWY-6005,1,0.9942311142053516,0,1,marneral biosynthesis,BioCyc
ARA:PWY-6007,1,0.989580004523919,0,2,arabidiol biosynthesis,BioCyc
ARA:PWY-601,1,0.7382150211038213,0,30,glucosinolate biosynthesis from tryptophan,BioCyc
ARA:PWY-6012,1,0.9599236912203987,0,4,acyl carrier protein metabolism,BioCyc
ARA:PWY-6014,1,0.9477201537767109,0,5,vernolate biosynthesis I,BioCyc
ARA:PWY-6019,1,0.9657651641664857,0,4,pseudouridine degradation,BioCyc
ARA:PWY-6039,1,0.8107483671793451,0,21,chlorogenic acid biosynthesis I,BioCyc
ARA:PWY-6040,1,0.8847981503366695,0,12,chlorogenic acid biosynthesis II,BioCyc
ARA:PWY-6051,1,0.92330871565831,0,8,"2,4,6-trinitrotoluene degradation",BioCyc
ARA:PWY-6064,1,0.9804407323837068,0,2,methylquercetin biosynthesis,BioCyc
ARA:PWY-6066,1,0.98461529975877915,0,2,IAA biosynthesis VII,BioCyc
ARA:PWY-6115,1,0.9426676531183771,0,9,"avenacin biosynthesis, initial reactions",BioCyc
ARA:PWY-6118,1,0.9413440523565814,0,8,glycerol-3-phosphate shuttle,BioCyc
ARA:PWY-6121,1,0.9389065827642926,0,7,5-aminoimidazole ribonucleotide biosynthesis I,BioCyc
ARA:PWY-6122,1,0.9389065827642926,0,7,5-aminoimidazole ribonucleotide biosynthesis II,BioCyc
ARA:PWY-6124,1,0.9601613459003449,0,6,inosine-5'-phosphate biosynthesis II,BioCyc
ARA:PWY-6132,1,0.9887399773844995,0,2,lanosterol biosynthesis,BioCyc
ARA:PWY-6137,1,0.95829108523447,0,6,copper transport II,BioCyc
ARA:PWY-6147,1,0.9403985059630954,0,6,6-hydroxymethyl-dihydropterin diphosphate biosynthesis I,BioCyc
ARA:PWY-6163,1,0.9314669846204865,0,9,chorismate biosynthesis from 3-dehydroquinate,BioCyc
ARA:PWY-6164,1,0.9602504304679229,0,5,3-dehydroquinate biosynthesis I,BioCyc
ARA:PWY-6196,1,0.978667350523018,0,2,D-serine metabolism,BioCyc
ARA:PWY-6199,1,0.9184307725716323,0,7,quercetin sulfate biosynthesis,BioCyc
ARA:PWY-621,1,0.797608361510276,0,29,sucrose degradation III (sucrose invertase),BioCyc
ARA:PWY-6213,1,0.967462556175564,0,6,cadmium transport I,BioCyc
ARA:PWY-6219,1,0.9239931936273322,0,10,indole-3-acetyl-amide conjugate biosynthesis,BioCyc
ARA:PWY-622,1,0.8169196541802867,0,33,starch biosynthesis,BioCyc
ARA:PWY-6220,1,0.9652968063386753,0,5,jasmonoyl-amino acid conjugates biosynthesis I,BioCyc
ARA:PWY-6232,1,0.9887408941212109,0,1,chrysoeriol biosynthesis,BioCyc
ARA:PWY-6233,1,0.9652968063386753,0,5,jasmonoyl-amino acid conjugates biosynthesis II,BioCyc
ARA:PWY-6235,1,0.9597206019176047,0,4,hydroxyjasmonate sulfate biosynthesis,BioCyc
ARA:PWY-6239,1,0.9904194494803027,0,1,luteolin glycosides biosynthesis,BioCyc
ARA:PWY-6266,1,0.6163732875089971,0,44,superpathway of flavones and derivatives biosynthesis,BioCyc
ARA:PWY-6266-ARA,1,0.6163732875089971,0,44,superpathway of flavones and derivatives biosynthesis,BioCyc
ARA:PWY-6287,1,0.9574957993460687,0,7,neurosporene biosynthesis,BioCyc
ARA:PWY-6295,1,0.975893052753281,0,2,olivetol biosynthesis,BioCyc
ARA:PWY-63,1,0.9220097979140182,0,11,UDP-L-arabinose biosynthesis I (from UDP-xylose),BioCyc
ARA:PWY-6303,1,0.9598105861094178,0,5,methyl indole-3-acetate interconversion,BioCyc
ARA:PWY-6304,1,0.9655841549191974,0,4,casbene biosynthesis,BioCyc
ARA:PWY-6305,1,0.9693679399790822,0,4,putrescine biosynthesis IV,BioCyc
ARA:PWY-6317,1,0.9065275640050601,0,15,D-galactose degradation I (Leloir pathway),BioCyc
ARA:PWY-6333,1,0.9080164211049727,0,12,acetaldehyde biosynthesis I,BioCyc
ARA:PWY-6348,1,0.7595858943549181,0,27,phosphate acquisition,BioCyc
ARA:PWY-6351,1,0.6844278805643328,0,52,"D-myo-inositol (1,4,5)-trisphosphate biosynthesis",BioCyc
ARA:PWY-6352,1,0.6772927034817047,0,63,3-phosphoinositide biosynthesis,BioCyc
ARA:PWY-6363,1,0.8633252332976865,0,20,"D-myo-inositol (1,4,5)-trisphosphate degradation",BioCyc
ARA:PWY-6364,1,0.9286720474793024,0,12,"D-myo-inositol (1,3,4)-trisphosphate biosynthesis",BioCyc
ARA:PWY-6367,1,0.8938138500202901,0,14,D-myo-inositol-5-phosphate metabolism,BioCyc
ARA:PWY-6369,1,0.9530135114564169,0,7,inositol pyrophosphates biosynthesis,BioCyc
ARA:PWY-6406,1,0.9879532064414451,0,2,salicylate biosynthesis I,BioCyc
ARA:PWY-6424,1,0.9766898994151325,0,2,"26,27-dehydrozymosterol metabolism",BioCyc
ARA:PWY-6441,1,0.9218057324396488,0,12,spermine and spermidine degradation III,BioCyc
ARA:PWY-6442,1,0.9433183130802373,0,5,spermidine hydroxycinnamic acid conjugates biosynthesis,BioCyc
ARA:PWY-6444,1,0.9075774850491958,0,15,"benzoate biosynthesis II (CoA-independent, non-&beta;-oxidative)",BioCyc
ARA:PWY-6446,1,0.8626387469133163,0,20,"benzoate biosynthesis III (CoA-dependent, non-&beta;-oxidative)",BioCyc
ARA:PWY-6457,1,0.932662145052977,0,8,trans-cinnamoyl-CoA biosynthesis,BioCyc
ARA:PWY-6466,1,0.930852619341749,0,6,pyridoxal 5'-phosphate biosynthesis II,BioCyc
ARA:PWY-6473,1,0.9823786307698392,0,3,4-aminobutanoate degradation IV,BioCyc
ARA:PWY-6475,1,0.9110339648050529,0,13,trans-lycopene biosynthesis II (plants),BioCyc
ARA:PWY-6483,1,0.9373646508160425,0,10,ceramide degradation,BioCyc
ARA:PWY-6498,1,0.9294791328441269,0,6,eumelanin biosynthesis,BioCyc
ARA:PWY-6502,1,0.9865477006216694,0,1,oxidized GTP and dGTP detoxification,BioCyc
ARA:PWY-6520,1,0.9701816585411792,0,4,nonaprenyl diphosphate biosynthesis II,BioCyc
ARA:PWY-6527,1,0.9122695707097866,0,13,stachyose degradation,BioCyc
ARA:PWY-6535,1,0.9823786307698392,0,3,4-aminobutanoate degradation I,BioCyc
ARA:PWY-6543,1,0.9516773523446627,0,5,4-aminobenzoate biosynthesis,BioCyc
ARA:PWY-6544,1,0.9267768581948381,0,11,superpathway of C28 brassinosteroid biosynthesis,BioCyc
ARA:PWY-6545,1,0.7584579221259253,0,29,pyrimidine deoxyribonucleotides de novo biosynthesis III,BioCyc
ARA:PWY-6546,1,0.9106918815127896,0,9,brassinosteroids inactivation,BioCyc
ARA:PWY-6549,1,0.7686105570761378,0,37,L-glutamine biosynthesis III,BioCyc
ARA:PWY-6554,1,0.8762522639095195,0,15,"1D-myo-inositol hexakisphosphate biosynthesis V (from Ins(1,3,4)P3)",BioCyc
ARA:PWY-6556,1,0.9672691496330058,0,3,pyrimidine ribonucleosides salvage II,BioCyc
ARA:PWY-6577,1,0.9772661803999141,0,3,farnesylcysteine salvage pathway,BioCyc
ARA:PWY-6596,1,0.8536165516619797,0,23,adenosine nucleotides degradation I,BioCyc
ARA:PWY-6599,1,0.9751173552268149,0,2,guanine and guanosine salvage II,BioCyc
ARA:PWY-66,1,0.9298984982451296,0,6,GDP-L-fucose biosynthesis I (from GDP-D-mannose),BioCyc
ARA:PWY-6605,1,0.8998135698030313,0,13,adenine and adenosine salvage II,BioCyc
ARA:PWY-6606,1,0.8907129554107606,0,16,guanosine nucleotides degradation II,BioCyc
ARA:PWY-6607,1,0.902556172973962,0,15,guanosine nucleotides degradation I,BioCyc
ARA:PWY-6612,1,0.894870790206463,0,11,superpathway of tetrahydrofolate biosynthesis,BioCyc
ARA:PWY-6613,1,0.9269613424061497,0,8,"tetrahydrofolate salvage from 5,10-methenyltetrahydrofolate",BioCyc
ARA:PWY-6614,1,0.9457234820383867,0,8,tetrahydrofolate biosynthesis,BioCyc
ARA:PWY-6619,1,0.9871306112574374,0,2,adenine and adenosine salvage VI,BioCyc
ARA:PWY-6623,1,0.9677924900322158,0,3,salicylate glucosides biosynthesis II,BioCyc
ARA:PWY-6624,1,0.977078630133624,0,2,salicylate glucosides biosynthesis III,BioCyc
ARA:PWY-6666,1,0.9791562510352204,0,2,pyocyanin biosynthesis,BioCyc
ARA:PWY-6673,1,0.925137873537403,0,9,caffeoylglucarate biosynthesis,BioCyc
ARA:PWY-6707,1,0.9938250198863957,0,1,gallate biosynthesis,BioCyc
ARA:PWY-6710,1,0.9477201537767109,0,5,poly-hydroxy fatty acids biosynthesis,BioCyc
ARA:PWY-6724,1,0.8962091442224254,0,15,starch degradation II,BioCyc
ARA:PWY-6730,1,0.955790985866839,0,5,methylhalides biosynthesis (plants),BioCyc
ARA:PWY-6733,1,0.7222210880826023,0,39,sporopollenin precursors biosynthesis,BioCyc
ARA:PWY-6736,1,0.9743045874187481,0,3,sulfur volatiles biosynthesis,BioCyc
ARA:PWY-6745,1,0.9386257509351018,0,8,phytochelatins biosynthesis,BioCyc
ARA:PWY-6754,1,0.9145896231189615,0,9,S-methyl-5'-thioadenosine degradation I,BioCyc
ARA:PWY-6756,1,0.939323109830126,0,6,S-methyl-5'-thioadenosine degradation II,BioCyc
ARA:PWY-6762,1,0.977078630133624,0,2,salicylate glucosides biosynthesis IV,BioCyc
ARA:PWY-6773,1,0.9257429545064643,0,19,"1,3-&beta;-D-glucan biosynthesis",BioCyc
ARA:PWY-6786,1,0.8512006760945384,0,15,detoxification of reactive carbonyls in chloroplasts,BioCyc
ARA:PWY-6787,1,0.7531040911997204,0,27,flavonoid biosynthesis (in equisetum),BioCyc
ARA:PWY-6799,1,0.9863919683317297,0,2,fatty acid biosynthesis (plant mitochondria),BioCyc
ARA:PWY-6802,1,0.9848279018458169,0,2,salidroside biosynthesis,BioCyc
ARA:PWY-6804,1,0.9613536967481545,0,5,diacylglycerol biosynthesis (PUFA enrichment in oilseed),BioCyc
ARA:PWY-6806,1,0.9779240626283813,0,3,carotenoid cleavage,BioCyc
ARA:PWY-6823,1,0.8313042740741571,0,20,molybdenum cofactor biosynthesis,BioCyc
ARA:PWY-6825,1,0.917569829776313,0,7,phosphatidylcholine biosynthesis V,BioCyc
ARA:PWY-6837,1,0.8984188175545798,0,12,"fatty acid beta-oxidation V (unsaturated, odd number, di-isomerase-dependent)",BioCyc
ARA:PWY-6845,1,0.9766199090936364,0,3,nitric oxide biosynthesis (plants),BioCyc
ARA:PWY-6890,1,0.9860744454670297,0,2,4-amino-2-methyl-5-diphosphomethylpyrimidine biosynthesis,BioCyc
ARA:PWY-6898,1,0.916202875697309,0,8,thiamine salvage III,BioCyc
ARA:PWY-6908,1,0.8876594574175257,0,11,thiamine diphosphate biosynthesis IV (eukaryotes),BioCyc
ARA:PWY-6909,1,0.9888019891474714,0,1,thiazole biosynthesis III (eukaryotes),BioCyc
ARA:PWY-6910,1,0.9924277997880095,0,1,hydroxymethylpyrimidine salvage,BioCyc
ARA:PWY-6922,1,0.9449740290507205,0,7,L-N&delta;-acetylornithine biosynthesis,BioCyc
ARA:PWY-6927,1,0.8853895256615176,0,14,chlorophyll a degradation II,BioCyc
ARA:PWY-6930,1,0.9556590670533165,0,4,phenolic malonylglucosides biosynthesis,BioCyc
ARA:PWY-6931,1,0.9951335177668099,0,1,seleno-amino acid detoxification and volatilization I,BioCyc
ARA:PWY-6932,1,0.9825124553048368,0,2,selenate reduction,BioCyc
ARA:PWY-6936,1,0.9138145756395123,0,10,seleno-amino acid biosynthesis,BioCyc
ARA:PWY-6938,1,0.9852538823691955,0,2,NADH repair,BioCyc
ARA:PWY-695,1,0.8913947958838193,0,12,abscisic acid biosynthesis,BioCyc
ARA:PWY-6952,1,0.8765146242516431,0,18,glycerophosphodiester degradation,BioCyc
ARA:PWY-6959,1,0.8683633458895369,0,16,L-ascorbate degradation V,BioCyc
ARA:PWY-6963,1,0.9127365012994361,0,13,ammonia assimilation cycle I,BioCyc
ARA:PWY-6964,1,0.9164479228652564,0,12,ammonia assimilation cycle II,BioCyc
ARA:PWY-6982,1,0.889831452752418,0,14,umbelliferone biosynthesis,BioCyc
ARA:PWY-699,1,0.9267768581948381,0,11,brassinosteroid biosynthesis I,BioCyc
ARA:PWY-701,1,0.9893462468743379,0,1,L-methionine degradation II,BioCyc
ARA:PWY-7036,1,0.7713846127159968,0,31,very long chain fatty acid biosynthesis II,BioCyc
ARA:PWY-7039,1,0.6865070474288602,0,52,"phosphatidate metabolism, as a signaling molecule",BioCyc
ARA:PWY-7047,1,0.9387571435397517,0,7,malate-oxaloacetate shuttle I,BioCyc
ARA:PWY-7048,1,0.9534633204681128,0,5,malate-oxaloacetate shuttle II,BioCyc
ARA:PWY-7060,1,0.9480102464565956,0,7,ornithine-citrulline shuttle,BioCyc
ARA:PWY-7061,1,0.963519057782555,0,6,glutamate-glutamine shuttle,BioCyc
ARA:PWY-7067,1,0.9564776130903362,0,4,betulinate biosynthesis,BioCyc
ARA:PWY-7068,1,0.9564776130903362,0,4,ursolate biosynthesis,BioCyc
ARA:PWY-7071,1,0.9766507656718153,0,2,steviol glucoside biosynthesis (rebaudioside A biosynthesis),BioCyc
ARA:PWY-7101,1,0.9704841022113244,0,3,5-deoxystrigol biosynthesis,BioCyc
ARA:PWY-7120,1,0.943970120588186,0,6,esterified suberin biosynthesis,BioCyc
ARA:PWY-7140,1,0.9747363093342774,0,3,myricetin gentiobioside biosynthesis,BioCyc
ARA:PWY-7158,1,0.9799232793796674,0,2,L-phenylalanine degradation V,BioCyc
ARA:PWY-7170,1,0.9808051079180301,0,2,phytochromobilin biosynthesis,BioCyc
ARA:PWY-7183,1,0.9307633998318868,0,11,pyrimidine nucleobases salvage I,BioCyc
ARA:PWY-7184,1,0.7284013654798286,0,35,pyrimidine deoxyribonucleotides de novo biosynthesis I,BioCyc
ARA:PWY-7187,1,0.7968681668753809,0,23,pyrimidine deoxyribonucleotides de novo biosynthesis II,BioCyc
ARA:PWY-7193,1,0.8921983782894328,0,16,pyrimidine ribonucleosides salvage I,BioCyc
ARA:PWY-7197,1,0.8484018829339829,0,15,pyrimidine deoxyribonucleotide phosphorylation,BioCyc
ARA:PWY-7199,1,0.9058741064480449,0,11,pyrimidine deoxyribonucleosides salvage,BioCyc
ARA:PWY-7200,1,0.7681538502976477,0,26,superpathway of pyrimidine deoxyribonucleoside salvage,BioCyc
ARA:PWY-7204,1,0.8640567541741156,0,16,pyridoxal 5'-phosphate salvage II (plants),BioCyc
ARA:PWY-7205,1,0.8501360727706587,0,15,CMP phosphorylation,BioCyc
ARA:PWY-7206,1,0.9259853036684819,0,7,pyrimidine deoxyribonucleotides dephosphorylation,BioCyc
ARA:PWY-7213,1,0.9474035396900029,0,7,wogonin metabolism,BioCyc
ARA:PWY-7219,1,0.6450462016902171,0,42,adenosine ribonucleotides de novo biosynthesis,BioCyc
ARA:PWY-7221,1,0.8353059788514026,0,19,guanosine ribonucleotides de novo biosynthesis,BioCyc
ARA:PWY-7224,1,0.8660668230518992,0,14,purine deoxyribonucleosides salvage,BioCyc
ARA:PWY-7226,1,0.8834608273041507,0,12,guanosine deoxyribonucleotides de novo biosynthesis I,BioCyc
ARA:PWY-7227,1,0.8834608273041507,0,12,adenosine deoxyribonucleotides de novo biosynthesis,BioCyc
ARA:PWY-7238,1,0.7736816555967256,0,39,sucrose biosynthesis II,BioCyc
ARA:PWY-7250,1,0.9897482462246968,0,1,[2Fe-2S] iron-sulfur cluster biosynthesis,BioCyc
ARA:PWY-7267,1,0.9562963701975714,0,4,anthocyanin biosynthesis (pelargonidin 3-O-glucoside),BioCyc
ARA:PWY-7325,1,0.9907641915604445,0,1,salvigenin biosynthesis,BioCyc
ARA:PWY-7343,1,0.9210203034642469,0,14,UDP-glucose biosynthesis,BioCyc
ARA:PWY-7344,1,0.9558998437367183,0,6,UDP-D-galactose biosynthesis,BioCyc
ARA:PWY-7346,1,0.956321288281489,0,5,UDP-&alpha;-D-glucuronate biosynthesis (from UDP-glucose),BioCyc
ARA:PWY-735,1,0.8161584798149271,0,25,jasmonic acid biosynthesis,BioCyc
ARA:PWY-7356,1,0.8705533943459588,0,13,thiamine salvage IV (yeast),BioCyc
ARA:PWY-7388,1,0.773659605531861,0,30,"octanoyl-[acyl-carrier protein] biosynthesis (mitochondria, yeast)",BioCyc
ARA:PWY-7432,1,0.90313219225037,0,11,"L-phenylalanine biosynthesis III (cytosolic, plants)",BioCyc
ARA:PWY-7436,1,0.9713426342301188,0,3,vitamin E biosynthesis (tocotrienols),BioCyc
ARA:PWY-7468,1,0.977078630133624,0,2,benzoyl-&beta;-D-glucopyranose biosynthesis,BioCyc
ARA:PWY-7528,1,0.7609834502617063,0,28,L-methionine salvage cycle I (bacteria and plants),BioCyc
ARA:PWY-7560,1,0.8783681776124329,0,17,methylerythritol phosphate pathway II,BioCyc
ARA:PWY-7590,1,0.9765406830558785,0,3,"(7Z,10Z,13Z)-hexadecatrienoate biosynthesis",BioCyc
ARA:PWY-762,1,0.9182663541416921,0,9,phospholipid desaturation,BioCyc
ARA:PWY-7625,1,0.9603524859679314,0,5,phosphatidylinositol biosynthesis II (eukaryotes),BioCyc
ARA:PWY-782,1,0.9255142291775976,0,9,glycolipid desaturation,BioCyc
ARA:PWY-7985,1,0.9759609852251692,0,3,oxalate degradation VI,BioCyc
ARA:PWY-801,1,0.9614749857857561,0,5,L-homocysteine and L-cysteine interconversion,BioCyc
ARA:PWY-82,1,0.9836750030146644,0,3,UDP-L-arabinose biosynthesis II (from L-arabinose),BioCyc
ARA:PWY-83,1,0.9895397817013525,0,1,monolignol glucosides biosynthesis,BioCyc
ARA:PWY-84,1,0.975893052753281,0,2,resveratrol biosynthesis,BioCyc
ARA:PWY-841,1,0.8834608273041507,0,12,superpathway of purine nucleotides de novo biosynthesis I,BioCyc
ARA:PWY-861,1,0.9194205980199016,0,8,dhurrin biosynthesis,BioCyc
ARA:PWY-882,1,0.8206726778733042,0,26,L-ascorbate biosynthesis I (L-galactose pathway),BioCyc
ARA:PWY-922,1,0.8686506111661654,0,20,mevalonate pathway I,BioCyc
ARA:PWY0-1021,1,0.9758885130950504,0,3,L-alanine biosynthesis III,BioCyc
ARA:PWY0-1182,1,0.9495248264098191,0,8,trehalose degradation II (trehalase),BioCyc
ARA:PWY0-1264,1,0.9410941218722403,0,10,biotin-carboxyl carrier protein assembly,BioCyc
ARA:PWY0-1313,1,0.939560423831219,0,10,acetate conversion to acetyl-CoA,BioCyc
ARA:PWY0-1319,1,0.9054800945938287,0,13,CDP-diacylglycerol biosynthesis II,BioCyc
ARA:PWY0-1325,1,0.9630637211173195,0,6,superpathway of L-asparagine biosynthesis,BioCyc
ARA:PWY0-1507,1,0.9210761361616822,0,10,biotin biosynthesis from 8-amino-7-oxononanoate I,BioCyc
ARA:PWY0-1535,1,0.978667350523018,0,2,D-serine degradation,BioCyc
ARA:PWY0-166,1,0.7776846783156085,0,26,superpathway of pyrimidine deoxyribonucleotides de novo biosynthesis (E. coli),BioCyc
ARA:PWY0-461,1,0.9516381564745909,0,5,L-lysine degradation I,BioCyc
ARA:PWY0-501,1,0.9347954308269745,0,6,lipoate biosynthesis and incorporation I,BioCyc
ARA:PWY0-541,1,0.977501899458745,0,4,cyclopropane fatty acid (CFA) biosynthesis,BioCyc
ARA:PWY0-662,1,0.938068189904382,0,8,PRPP biosynthesis I,BioCyc
ARA:PWY0A-6303,1,0.8796708086676228,0,13,methyl indole-3-acetate interconversion,BioCyc
ARA:PWY1F-353,1,0.9783425415600006,0,3,glycine betaine biosynthesis III (plants),BioCyc
ARA:PWY1F-467,1,0.9724611794096519,0,4,"phenylpropanoid biosynthesis, initial reactions",BioCyc
ARA:PWY1F-823,1,0.9594216868064822,0,4,leucopelargonidin and leucocyanidin biosynthesis,BioCyc
ARA:PWY1F-FLAVSYN,1,0.7298490524662173,0,33,flavonoid biosynthesis,BioCyc
ARA:PWY3DJ-35471,1,0.9672910023193595,0,4,L-ascorbate biosynthesis IV,BioCyc
ARA:PWY3O-450,1,0.9188309829501325,0,11,phosphatidylcholine biosynthesis I,BioCyc
ARA:PWY490-4,1,0.9638949313849906,0,4,L-asparagine biosynthesis III (tRNA-dependent),BioCyc
ARA:PWY4FS-10,1,0.9782970668225236,0,2,scopolin biosynthesis,BioCyc
ARA:PWY4FS-11,1,0.9742685674124006,0,4,L-ascorbate biosynthesis II (L-gulose pathway),BioCyc
ARA:PWY4FS-12,1,0.985507282626301,0,2,VTC2 cycle,BioCyc
ARA:PWY4FS-13,1,0.985507282626301,0,2,extended VTC2 cycle,BioCyc
ARA:PWY4FS-2,1,0.9021832917438795,0,15,phosphatidylcholine biosynthesis II,BioCyc
ARA:PWY4FS-3,1,0.9319274938482867,0,9,phosphatidylcholine biosynthesis III,BioCyc
ARA:PWY4FS-4,1,0.9319274938482867,0,9,phosphatidylcholine biosynthesis IV,BioCyc
ARA:PWY4FS-5,1,0.8561236149884736,0,20,superpathway of phosphatidylcholine biosynthesis,BioCyc
ARA:PWY4FS-6,1,0.905541648223631,0,13,phosphatidylethanolamine biosynthesis II,BioCyc
ARA:PWY4FS-7,1,0.8675431625305274,0,17,phosphatidylglycerol biosynthesis I (plastidic),BioCyc
ARA:PWY4FS-8,1,0.768882213950338,0,32,phosphatidylglycerol biosynthesis II (non-plastidic),BioCyc
ARA:PWY66-21,1,0.7887618089391809,0,34,ethanol degradation II,BioCyc
ARA:PWY66-423,1,0.950295662302198,0,5,"fructose 2,6-bisphosphate biosynthesis",BioCyc
ARA:PWYDQC-4,1,0.9384127567489885,0,7,indole-3-acetate biosynthesis I,BioCyc
ARA:PWYQT-1,1,0.9662398282680048,0,6,lysine degradation III,BioCyc
ARA:PWYQT-4427,1,0.9792116974700373,0,3,sulfoquinovosyl diacylglycerol biosynthesis,BioCyc
ARA:PWYQT-4429,1,0.9596640162501898,0,7,CO2 fixation into oxaloacetate (anaplerotic),BioCyc
ARA:PWYQT-4432,1,0.9620947590540451,0,5,glutathione degradation,BioCyc
ARA:PWYQT-4433,1,0.9718091036340086,0,4,CA1P biosynthesis,BioCyc
ARA:PWYQT-4445,1,0.8539573424007411,0,23,pyrimidine salvage pathway,BioCyc
ARA:PWYQT-4449,1,0.8349792932709307,0,16,polyisoprenoid biosynthesis,BioCyc
ARA:PWYQT-4466,1,0.6747685805795065,0,54,superpathway of sucrose and starch metabolism I (non-photosynthetic tissue),BioCyc
ARA:PWYQT-4470,1,0.9758487546959418,0,4,&gamma;-glutamyl cycle (plant pathway),BioCyc
ARA:PWYQT-4477,1,0.8494677732442277,0,16,indole glucosinolate activation (intact plant cell),BioCyc
ARA:PWYQT-4481,1,0.6714332694021933,0,44,TCA cycle variation V (plant),BioCyc
ARA:PWYQT-4482,1,0.9270519714350779,0,9,CDP-diacylglycerol biosynthesis IV,BioCyc
ARA:PWYQT-62,1,0.7630899939192597,0,33,superpathway of proto- and siroheme biosynthesis,BioCyc
ARA:PWYQT-94,1,0.8551398606871522,0,17,superpathway of polyamine biosynthesis,BioCyc
ARA:PYRIDNUCSYN-PWY,1,0.945433417734812,0,7,NAD biosynthesis I (from aspartate),BioCyc
ARA:PYRUVDEHYD-PWY,1,0.8359735859971628,0,22,pyruvate decarboxylation to acetyl CoA,BioCyc
ARA:RIBOSYN2-PWY,1,0.888618512825284,0,14,flavin biosynthesis I (bacteria and plants),BioCyc
ARA:SAM-PWY,1,0.9330059230644643,0,7,S-adenosyl-L-methionine biosynthesis,BioCyc
ARA:SERSYN-PWY,1,0.9476245219125834,0,6,L-serine biosynthesis,BioCyc
ARA:SUCSYN-PWY,1,0.7139763746889356,0,40,sucrose biosynthesis I (from photosynthesis),BioCyc
ARA:SULFMETII-PWY,1,0.9214466738109386,0,9,sulfate reduction II (assimilatory),BioCyc
ARA:THIOREDOX-PWY,1,0.7965857490426761,0,19,thioredoxin pathway,BioCyc
ARA:TRESYN-PWY,1,0.8324576876060656,0,28,trehalose biosynthesis I,BioCyc
ARA:TRPSYN-PWY,1,0.8354015142646102,0,22,L-tryptophan biosynthesis,BioCyc
ARA:TYRFUMCAT-PWY,1,0.8787949130687869,0,14,L-tyrosine degradation I,BioCyc
ARA:UDPNACETYLGALSYN-PWY,1,0.9349284718253242,0,8,UDP-N-acetyl-D-glucosamine biosynthesis II,BioCyc
ARA:VALDEG-PWY,1,0.7951709829273764,0,30,L-valine degradation I,BioCyc
ARA:VALSYN-PWY,1,0.8913461735527668,0,17,L-valine biosynthesis,BioCyc
ARA:XYLCAT-PWY,1,0.9743406225205846,0,4,xylose degradation I,BioCyc
ARA:TRIGLSYN-PWY,1.0000000000000009,0.585985573358136,0,66,diacylglycerol and triacylglycerol biosynthesis,BioCyc
ARA:CALVIN-PWY,1.0000000000000029,0.6890309347710446,0,39,Calvin-Benson-Bassham cycle,BioCyc
